OHDSI Home | Forums | Wiki | Github

Primary Induction Failure (PIF)/Complete Response with Incomplete Hematologic Recover (CRi)

Looking for advice to map Primary Induction Failure (PIF) and

Complete Response with Incomplete Hematologic Recover (CRi)

1 Like

Bump

Bump

Bumpy road you are driving there, @jliddil1. :slight_smile:

PIF: This will be in the Episode Domain. Maybe not exactly as that, but each line of chemo is going to have an Episode, and so are relapses or progressive diseases. So Primary Induction Failure is going to be the progressive disease after the first chemo.

CRi: Need to add that Episode.

So for now I should wait to map?

Week or two.

A week or two has passed :slight_smile:

Are you planning on coming to the OHdSI Symposium? We can do it right there on the spot.

@jliddil1 What source data are you mapping that has data on response in AML?

@Christian_Reich, if you guys end up talking about at the symposium, please let me know - I’d love to be involved.

No my employer won’t fund attending
@esholle We collect hematologic data across all the various malignancies. We have Best Response questions for each type.

Looks like we are not talking at the Symposium, but I would suggest we bring it up at the next Oncology meeting. Tagging @mgurley. @esholle, please come as well.

@jliddil1: Instead of adding these piece meal one Forum Post at a time, can you drop the whole controlled vocabularies for your episodes in your hematological malignancies?

Best Response (AML/ALL) Complete Response (CR)
Complete Response with Incomplete Hematologic Recover (CRi)
Primary Induction Failure (PIF)
Relapse (REL)
Untreated
Best Response (CML) Complete Response (CR)
Chronic Phase
Accelerated Phase
Blast Phase
Relapse (REL)
Progressive Disease (Prog)
Best Response (CLL) Complete Response (CR)
Partial Response (PR)
No Response (NR)/Stable Disease (SD)
Progressive Disease (Prog)
Untreated
Not Assessed
Best Response (MDS/MPN) Complete Response (CR)
Hematologic Improvement (HI)
Hematologic Improvement - erythropoietic (HI-E)
Hematologic Improvement - platelets (HI-P)
Hematologic Improvement - neutrophils (HI-N)
No Response (NR)/Stable Disease (SD)
Progression from Hematologic Improvement (Prog from HI)
Relapse (REL)
Progression to AML
Best Response (JMML) Complete Response (CR)
Partial Response (PR)
Marginal Response (MR)
No Response (NR)/Stable Disease (SD)
Progressive Disease (Prog)
Relapse (REL)
Not Assessed
Best Response (MM/PCL) 2 Stringent Complete Response (sCR)
Complete Response (CR)
Near Complete Response (nCR)
Very Good Response (VGR)
Partial Response (PR)
No Response (NR)/Stable Disease (SD)
Progressive Disease (Prog)
Relapse (REL)
Best Response (Amyloidosis) Complete Response (CR)
Partial Response (PR)
No Response (NR)/Stable Disease (SD)
Progressive Disease (Prog)
Cardiac Response
Hepatic Response
Autonomic Neuropathy Response
Peripheral Neuropathy Response
Renal Response
Best Response (Lymphoma) Complete Response (CR)
Partial Response (PR)
No Response (NR)/Stable Disease (SD)
Progressive Disease (Prog)
Relapse (REL)
Radiographic Response Criteria
Metabolic Criteria
Best Response (Waldenstrom Macroglobulinemia) Complete Response (CR)
Partial Response (PR)
No Response (NR)/Stable Disease (SD)
Progressive Disease (Prog)
Not Assessed
Best Response (Solid Tumor) Objective Response (OR)
Complete Response (CR)
Partial Response (PR)
No Response (NR)/Stable Disease (SD)
Progressive Disease (Prog)
1 Like
t